332
Views
24
CrossRef citations to date
0
Altmetric
Review

Cutting balloons, covered stents and paclitaxel-coated balloons for the treatment of dysfunctional dialysis access

, , &
Pages 1119-1126 | Received 20 Sep 2016, Accepted 26 Oct 2016, Published online: 15 Nov 2016

References

  • Bittl JA. Catheter interventions for hemodialysis fistulas and grafts. JACC Cardiovasc Interv. 2010;3(1):1–11.
  • McCarley P. The KDOQI clinical practice guidelines and clinical practice recommendations for treating anemia in patients with chronic kidney disease: implications for nurses. Nephrol Nursing Journal Journal Am Nephrol Nurses’ Assoc. 2006;33(4):423–426. 445; quiz 427-428.
  • Haskal ZJ, Trerotola S, Dolmatch B, et al. Stent graft versus balloon angioplasty for failing dialysis-access grafts. N Engl J Med. 2010;362(6):494–503.
  • Diskin CJ. Novel insights into the pathobiology of the vascular access - do they translate into improved care? Blood Purif. 2010;29(2):216–229.
  • Kelly BS, Heffelfinger SC, Whiting JF, et al. Aggressive venous neointimal hyperplasia in a pig model of arteriovenous graft stenosis. Kidney Int. 2002;62(6):2272–2280.
  • Lee T, Roy-Chaudhury P. Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis. Adv Chronic Kidney Dis. 2009;16(5):329–338.
  • Agarwal AK, Haddad NJ, Khabiri H. How should symptomatic central vein stenosis be managed in hemodialysis patients? Semin Dial. 2014;27(3):278–281.
  • Funaki B. Cutting balloon angioplasty in arteriovenous fistulas. J Vasc Interv Radiol. 2005;16(1):5–7.
  • Song HH, Kim KT, Chung SK, et al. Cutting balloon angioplasty for resistant venous stenoses of Brescia-Cimino fistulas. J Vasc Interv Radiol. 2004;15(12):1463–1467.
  • Tsetis D, Morgan R, Belli AM. Cutting balloons for the treatment of vascular stenoses. Eur Radiol. 2006;16(8):1675–1683.
  • Rasuli P, Chennur VS, Connolly MJ, et al. Randomized trial comparing the primary patency following cutting versus high-pressure balloon angioplasty for treatment of de novo venous stenoses in hemodialysis arteriovenous fistulae. J Vasc Interv Radiol. 2015;26(12):1840-6.e1.
  • Vesely TM, Siegel JB. Use of the peripheral cutting balloon to treat hemodialysis-related stenoses. J Vasc Interv Radiol. 2005;16(12):1593–1603.
  • Saleh HM, Gabr AK, Tawfik MM, et al. randomized study of cutting balloon angioplasty versus conventional balloon angioplasty for the treatment of hemodialysis access stenoses. J Vasc Surg. 2014;60(3):735–740.
  • Aftab SA, Tay KH, Irani FG, et al. Randomized clinical trial of cutting balloon angioplasty versus high-pressure balloon angioplasty in hemodialysis arteriovenous fistula stenoses resistant to conventional balloon angioplasty. J Vasc Interv Radiol. 2014;25(2):190–198.
  • Bhat R, McBride K, Chakraverty S, et al. Primary cutting balloon angioplasty for treatment of venous stenoses in native hemodialysis fistulas: long-term results from three centers. Cardiovasc Intervent Radiol. 2007;30(6):1166-1170; discussion 1171-1162.
  • Heerwagen ST, Lonn L, Schroeder TV, et al. Cephalic arch stenosis in autogenous brachiocephalic hemodialysis fistulas: results of cutting balloon angioplasty. J Vasc Access. 2010;11(1):41–45.
  • Wu CC, Lin MC, Pu SY, et al. Comparison of cutting balloon versus high-pressure balloon angioplasty for resistant venous stenoses of native hemodialysis fistulas. J Vasc Interv Radiol. 2008;19(6):877–883.
  • Agarwal SK, Nadkarni GN, Yacoub R, et al. Comparison of cutting balloon angioplasty and percutaneous balloon angioplasty of arteriovenous fistula stenosis: a meta-analysis and systematic review of randomized clinical trials. J Interv Cardiol. 2015;28(3):288–295.
  • Katsanos K, Sabharwal T, Carrell T, et al. Peripheral endografts for the treatment of traumatic arterial injuries. Emerg Radiol. 2009;16(3):175–184.
  • Mwipatayi BP, Sharma S, Daneshmand A, et al. Durability of the balloon-expandable covered versus bare-metal stents in the Covered versus Balloon Expandable Stent Trial (COBEST) for the treatment of aortoiliac occlusive disease. J Vasc Surg. 2016;64(1):83-94.e1.
  • Golchehr B, Kruse R, van Walraven LA, et al. Three-year outcome of the heparin-bonded Viabahn for superficial femoral artery occlusive disease. J Vasc Surg. 2015;62(4):984–989.
  • Zhang L, Bao J, Zhao Z, et al. Effectiveness of Viabahn in the treatment of superficial femoral artery occlusive disease: a systematic review and meta-analysis. J Endovasc Ther. 2015;22(4):495–505.
  • Haskal ZJ, Saad TF, Hoggard JG, et al. Prospective, randomized, concurrently-controlled study of a Stent Graft versus balloon angioplasty for treatment of arteriovenous access graft stenosis: 2-year results of the RENOVA study. J Vasc Interv Radiol. 2016;27(8):1105-1114.e3.
  • Karnabatidis D, Kitrou P, Spiliopoulos S, et al. Stent-grafts versus angioplasty and/or bare metal stents for failing arteriovenous grafts: a cross-over longitudinal study. J Nephrol. 2013;26(2):389–395.
  • Vesely T, DaVanzo W, Behrend T, et al. Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts. J Vasc Surg. 2016;64:1400-1410.e1.
  • Carmona J, Rits Y, Jones B, et al. Patency of the Viabahn stent graft for the treatment of outflow stenosis in hemodialysis grafts. Am J Surg. 2016;211(3):551–554.
  • Rajan DK, Falk A, Randomized Prospective A. Study comparing outcomes of angioplasty versus VIABAHN stent-graft placement for cephalic arch stenosis in dysfunctional hemodialysis accesses. J Vasc Interv Radiol. 2015;26(9):1355–1361.
  • Schmelter C, Raab U, Lazarus F, et al. Outcomes of AV fistulas and AV grafts after interventional stent-graft deployment in haemodialysis patients. Cardiovasc Intervent Radiol. 2015;38(4):878–886.
  • Kitrou P, Karnabatidis D, Katsanos K. Drug-coated balloons are replacing the need for nitinol stents in the superficial femoral artery. J Cardiovasc Surg (Torino). 2016;57(4):569–577.
  • Katsanos K, Karnabatidis D, Kitrou P, et al. Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial. J Endovasc Ther. 2012;19(2):263–272.
  • Kitrou PM, Spiliopoulos S, Katsanos K, et al. Paclitaxel-coated versus plain balloon angioplasty for dysfunctional arteriovenous fistulae: one-year results of a prospective randomized controlled trial. J Vasc Interv Radiol. 2015;26(3):348–354.
  • Kitrou PM, Katsanos K, Spiliopoulos S, et al. Drug-eluting versus plain balloon angioplasty for the treatment of failing dialysis access: final results and cost-effectiveness analysis from a prospective randomized controlled trial (NCT01174472). Eur J Radiol. 2015;84(3):418–423.
  • Lai CC, Fang HC, Tseng CJ, et al. Percutaneous angioplasty using a paclitaxel-coated balloon improves target lesion restenosis on inflow lesions of autogenous radiocephalic fistulas: a pilot study. J Vasc Interv Radiol. 2014;25(4):535–541.
  • Massmann A, Fries P, Obst-Gleditsch K, et al. Paclitaxel-coated balloon angioplasty for symptomatic central vein restenosis in patients with hemodialysis fistulas. J Endovasc Ther. 2015;22(1):74–79.
  • Verbeeck N, Pillet J-C, Toukouki A, et al.; Verbeeck Nea. Paclitaxel-coated Balloon angioplasty of venous stenoses in native dialysis fistulas: primary and secondary patencies at 6 and 12 months. J Belgian Soc Radiol. 2016;100(1):69.
  • Patane D, Giuffrida S, Morale W, et al. Drug-eluting balloon for the treatment of failing hemodialytic radiocephalic arteriovenous fistulas: our experience in the treatment of juxta-anastomotic stenoses. J Vasc Access. 2014;15(5):338–343.
  • III. NKF-K/DOQI Clinical Practice Guidelines for Vascular Access: update 2000. Am J Kidney Dis. 2001;37(1 Suppl 1):S137–S181.
  • Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560.
  • Nassar GM, Suki D, Rhee E, et al. Outcomes of arteriovenous grafts following simultaneous thrombectomy and stent graft placement across the venous anastomosis. Semin Dial. 2014;27(6):639–644.
  • Swinnen JJ, Zahid A, Burgess DC. Paclitaxel drug-eluting balloons to recurrent in-stent stenoses in autogenous dialysis fistulas: a retrospective study. J Vasc Access. 2015;16(5):388–393.
  • Simone S, Loverre A, Cariello M, et al. Arteriovenous fistula stenosis in hemodialysis patients is characterized by an increased adventitial fibrosis. J Nephrol. 2014;27(5):555–562.
  • Katsanos K, Spiliopoulos S, Paraskevopoulos I, et al. Systematic review and meta-analysis of randomized controlled trials of paclitaxel-coated Balloon angioplasty in the femoropopliteal arteries: role of paclitaxel dose and bioavailability. J Endovasc Ther. 2016;23(2):356–370.
  • Dolmatch BL. Stent graft versus balloon angioplasty for failing dialysis access grafts: a long-awaited advance in the treatment of permanent hemodialysis access. J Vasc Access. 2010;11(2):89–91.
  • Karunanithy N, Mesa IR, Dorling A, et al. Paclitaxel-coated balloon fistuloplasty versus plain balloon fistuloplasty only to preserve the patency of arteriovenous fistulae used for haemodialysis (PAVE): study protocol for a randomised controlled trial. Trials. 2016;17(1):241.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.